GVB Biopharma, a 22nd Century company, is a global-scale specialty ingredient supplier and contract development & manufacturing organization (CDMO) with manufacturing locations in Nevada and Oregon.
PRINEVILLE, Ore., Feb. 18, 2025 /PRNewswire/ -- GVB Biopharma, the largest global producer of cannabinoids, is proud to announce the launch of its cutting-edge isolation facility, marking a ...
Transaction Immediately Accretive and Will Double Company’s Total Revenue Adds Significant Commercial Scale to Existing Hemp/Cannabis Franchise GVB Biopharma has Achieved Strong Growth and Leading ...
VANCOUVER, BC / ACCESSWIRE / April 4, 2023 / Lords & Company Worldwide Holdings Inc. ("Lords" or the "Company") (CSE:LRDS)(OTCQB:LRDSF)(FSE:4XM), is pleased to announce the launch of seven new lines ...
BUFFALO, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp ...
BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback